P139 A phase I biological study of azacitidine (Vidaza) to determine the optimal biological dose and route of administration

Autor: Yang, A.S., Mohrbacher, A., Douer, D., Gorospe, G., Byun, H.-M.
Zdroj: In Leukemia Research 2009 33 Supplement 1:S140-S140
Databáze: ScienceDirect